Insider filing · GILD
Deborah H Telman
EVP, Corporate Affairs & GC
profile →
Gilead Sciences, Inc.
GILD · Healthcare · 88 filings in 24 months
ticker →
Deborah H Telman sold $6.5M of Gilead Sciences (GILD)
Executed Nov 12 2025, disclosed Nov 13 2025, 1 day later.
Value, as filed
$6.5M
53,146 sh across 2 lots
Executed
Nov 12 2025
the trade date, as filed
Disclosed
Nov 13 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DTDeborah H Telman (EVP, Corporate Affairs & GC) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $6.5M of GILD (53,146 sh across 2 lots, as filed), executed Nov 12 2025.
The name
GILDHealthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→